MORGAN STANLEY - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 43 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$5,541
-44.9%
7,932
-29.1%
0.00%
Q4 2022$10,065
-99.2%
11,183
-95.0%
0.00%
Q3 2022$1,342,000
+31.4%
223,816
-9.3%
0.00%
Q2 2022$1,021,000
+2072.3%
246,692
+1891.9%
0.00%
Q1 2022$47,000
-80.9%
12,385
-77.4%
0.00%
Q4 2021$246,000
-48.2%
54,720
-46.4%
0.00%
Q3 2021$475,000
-80.9%
102,090
-71.0%
0.00%
Q2 2021$2,484,000
-27.2%
352,453
-38.9%
0.00%
-100.0%
Q1 2021$3,410,000
-25.5%
577,022
-41.9%
0.00%0.0%
Q4 2020$4,580,000
+378.1%
993,623
+303.4%
0.00%
Q3 2020$958,000
+609.6%
246,335
+5155.7%
0.00%
Q2 2020$135,000
+48.4%
4,687
+10.4%
0.00%
Q1 2020$91,000
-22.2%
4,246
-28.5%
0.00%
Q4 2019$117,000
+5750.0%
5,936
+5836.0%
0.00%
Q3 2019$2,0001000.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,711,286$22,268,0003.58%
NEA Management Company, LLC 3,142,958$18,858,0000.94%
Vivo Capital, LLC 1,232,394$7,394,0000.82%
RA Capital Management 5,914,252$35,486,0000.76%
Nan Fung Group Holdings Ltd 177,900$1,067,0000.68%
Ikarian Capital, LLC 400,000$2,400,0000.48%
SAMLYN CAPITAL, LLC 2,929,195$17,575,0000.33%
EAM Investors, LLC 149,029$894,0000.19%
TPG GP A, LLC 1,885,939$11,316,0000.18%
Ikarian Capital, LLC 136,059$815,0000.16%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders